ATE148344T1 - Verwendung von 15-dehydroxy-16-oxoprostaglandin bei der behandlung von allergischen erkrankungen - Google Patents

Verwendung von 15-dehydroxy-16-oxoprostaglandin bei der behandlung von allergischen erkrankungen

Info

Publication number
ATE148344T1
ATE148344T1 AT91303667T AT91303667T ATE148344T1 AT E148344 T1 ATE148344 T1 AT E148344T1 AT 91303667 T AT91303667 T AT 91303667T AT 91303667 T AT91303667 T AT 91303667T AT E148344 T1 ATE148344 T1 AT E148344T1
Authority
AT
Austria
Prior art keywords
oxoprostaglandin
dehydroxy
treatment
allergy diseases
allergy
Prior art date
Application number
AT91303667T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE148344T1 publication Critical patent/ATE148344T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT91303667T 1990-04-27 1991-04-24 Verwendung von 15-dehydroxy-16-oxoprostaglandin bei der behandlung von allergischen erkrankungen ATE148344T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11230390 1990-04-27
JP6132791 1991-03-01

Publications (1)

Publication Number Publication Date
ATE148344T1 true ATE148344T1 (de) 1997-02-15

Family

ID=26402368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91303667T ATE148344T1 (de) 1990-04-27 1991-04-24 Verwendung von 15-dehydroxy-16-oxoprostaglandin bei der behandlung von allergischen erkrankungen

Country Status (10)

Country Link
EP (1) EP0454429B1 (de)
JP (1) JPH07103030B2 (de)
KR (1) KR970005173B1 (de)
AT (1) ATE148344T1 (de)
AU (1) AU639322B2 (de)
CA (1) CA2041240C (de)
DE (1) DE69124415T2 (de)
DK (1) DK0454429T3 (de)
ES (1) ES2099736T3 (de)
GR (1) GR3022706T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654339A (en) * 1992-08-07 1997-08-05 Schering Aktiengesellschaft Use of prostane derivatives of formulate I and II for treatment of chronic polyarthritis
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
EP2699244A4 (de) * 2011-04-19 2014-10-22 Sucampo Ag Verfahren zur modulation einer cytokinaktivität
US20120277299A1 (en) * 2011-04-27 2012-11-01 Sucampo Ag Method for modulating ion transporter
US20140212441A1 (en) * 2011-06-21 2014-07-31 R-Tech Ueno, Ltd. Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases
WO2015049876A1 (ja) * 2013-10-04 2015-04-09 国立大学法人東北大学 腎機能障害の予防又は改善剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3836667A (en) * 1972-03-24 1974-09-17 Miles Lab Method of producing bronchodilation
GB1507211A (en) * 1975-02-14 1978-04-12 Ono Pharmaceutical Co Prostaglandin analogues
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
US4879285A (en) * 1986-08-22 1989-11-07 Royal North Shore Hospital And Area Health Service Fertility control
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
DE69025787T2 (de) * 1989-04-04 1996-10-31 Beiersdorf Ag Mittel zur Atopieprophylaxe
DK0444844T3 (da) * 1990-02-26 1995-04-03 R Tech Ueno Ltd Hidtil ukendte 15-dehydroxy-16-oxoprostaglandiner

Also Published As

Publication number Publication date
GR3022706T3 (en) 1997-05-31
DE69124415T2 (de) 1997-05-15
DK0454429T3 (da) 1997-03-17
AU639322B2 (en) 1993-07-22
JPH07103030B2 (ja) 1995-11-08
ES2099736T3 (es) 1997-06-01
CA2041240A1 (en) 1991-10-28
EP0454429A2 (de) 1991-10-30
DE69124415D1 (de) 1997-03-13
KR970005173B1 (ko) 1997-04-14
JPH04330015A (ja) 1992-11-18
AU7593091A (en) 1991-11-07
EP0454429B1 (de) 1997-01-29
CA2041240C (en) 2001-07-31
EP0454429A3 (en) 1992-07-15
KR910018028A (ko) 1991-11-30

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
ATE143263T1 (de) Behandlung von neurodegenerativen erkrankungen
DE69200675D1 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
ATE110556T1 (de) Verbesserungen bei der behandlung von zähnen.
DE69004081D1 (de) Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
FI913045A (fi) Heterocyklenderivat.
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE69008342D1 (de) Orthese für die Behandlung von Schienbeinverdrehungen bei Kindern.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
DE69024744D1 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
ATE148344T1 (de) Verwendung von 15-dehydroxy-16-oxoprostaglandin bei der behandlung von allergischen erkrankungen
DE69622889D1 (de) Substituierte 4-(1h-benzimidazol-2-yl)(1,4)diazepane für die behandlung von allergischen krankheiten
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen
AT400095B (de) Zahnärztliches handstück für die behandlung von zähnen mit laserstrahlen
DE69632117D1 (de) Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten
DE69228235D1 (de) Verwendung eines Mittels zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee